Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level

References

• Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006;61:158–163
   PubMed Web of Science ®Google Scholar
• Kim U, Hwang JM. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography. Eur J Ophthalmol 2009;19:466–469
   PubMed Web of Science ®Google Scholar
• Chai SJ, Foroozan R. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Br J Ophthalmol 2007;91:895–897
   PubMed Web of Science ®Google Scholar
• Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2005;243:410–416
   PubMed Web of Science ®Google Scholar
• Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56–60
   PubMedGoogle Scholar
• Fraunfelder FW, Sadun AA, Wood T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf 2006;5:615–618
   PubMed Web of Science ®Google Scholar
• Lee EJ, Kim SJ, Choung HK, et al. Incidence and clinical features of ethambutol-induced optic neuropathy in korea. J Neuroophthalmol 2008;28:269–277
   PubMed Web of Science ®Google Scholar
• Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther 1997;13:473–477
   PubMed Web of Science ®Google Scholar
• Kumar A, Sandramouli S, Verma L, et al. Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol 1993;13:15–17.
   PubMedGoogle Scholar
• Menon V, Jain D, Saxena R, Sood R. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol 2009;93:1251–1254
   PubMed Web of Science ®Google Scholar
• Kim YK, Hwang JM. Serial retinal nerve fiber layer changes in patients with toxic optic neuropathy associated with antituberculosis pharmacotherapy. J Ocul Pharmacol Ther 2009;25:531–535
   PubMed Web of Science ®Google Scholar
• Mantyjarvi M, Laitinen T. Normal values for the Pelli–Robson contrast sensitivity test. J Cataract Refract Surg 2001;27:261–266
   PubMed Web of Science ®Google Scholar
• Choi SY, Hwang JM. Optic neuropathy associated with ethambutol in Koreans. Korean J Ophthalmol 1997;11:106–110
   PubMedGoogle Scholar
• Salmon JF, Carmichael TR, Welsh NH. Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy. Br J Ophthalmol 1987;71:192–196
   PubMed Web of Science ®Google Scholar
• Yiannikas C, Walsh JC, McLeod JG. Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol. Arch Neurol 1983;40:645648
   Google Scholar
• Kardon RH, Morrisey MC, Lee AG. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity. Semin Ophthalmol 2006;21:215–222
   PubMedGoogle Scholar
• Hennekes R. Clinical ERG findings in ethambutol intoxication. Graefes Arch Clin Exp Ophthalmol 1982;218:319–321
   PubMed Web of Science ®Google Scholar
• Zoumalan CI, Sadun AA. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy. Br J Ophthalmol 2007;91:839–840
   PubMed Web of Science ®Google Scholar
• Kim BK, Ahn M. The use of optical coherence tomography in patients with ethambutol-induced optic neuropathy. J Korean Ophthalmol Soc 2010;51:1107–1112
   Google Scholar
• Yoo YH, Jung KH, Sadun AA, et al. Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc. Toxicol Appl Pharmacol 2000;162:107–114
   PubMed Web of Science ®Google Scholar
• Sokol S. Pattern visual evoked potentials: their use in pediatric ophthalmology. Int Ophthalmol Clin 1980;20:251–268
   PubMedGoogle Scholar
• Oken BS, Chiappa KH, Gill E. Normal temporal variability of the P100. Electroencephalogr Clin Neurophysiol 1987;68:153–156
   PubMedGoogle Scholar
• Matsuoka Y, Takayanagi T, Sobue I. Experimental ethambutol neuropathy in rats. Morphometric and teased-fiber studies. J Neurol Sci 1981;51:89–99
   PubMed Web of Science ®Google Scholar
• Tateishi J, Kuroda S, Otsuki S. Experimental myelo-optico-neuropathy due to ethambutol. Folia Psychiatr Neurol Jpn 1974;28:233–242
   PubMedGoogle Scholar
• Şahin A, Kürşat Cingü A, Kaya S, et al. The protective effects of caffeic acid phenethyl ester in isoniazid and ethambutol-induced ocular toxicity of rats. Cutan Ocul Toxicol 2013;32:228–233
   PubMed Web of Science ®Google Scholar
• Talbert Estlin KA, Sadun AA. Risk factors for ethambutol optic toxicity. Int Ophthalmol 2010;30:63–72
   PubMedGoogle Scholar
• Budenz DL, Chang RT, Huang X, et al. Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2005;46:2440–2443
   PubMed Web of Science ®Google Scholar